Newsletter Subject

New COVID Variant XEC May Outpace Others This Fall

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Sep 21, 2024 11:15 AM

Email Preheader Text

Weekly Review Saturday, September 21, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT

[MEDPAGE TODAY]( Weekly Review Saturday, September 21, 2024 [New COVID Variant XEC May Outpace Others This Fall]( [Eye Drop Company in FDA's Sights Once Again]( [California Clarifies Role of CRNAs Amid Scope-of-Practice Clash]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Infusion Therapies to Advance Care in Metastatic HR+/HER2- and Triple-Negative Breast Cancer]( [Docs Accused of Treating Fatal COVID With Peroxide; Cardiologists' Defamation Suit]( [Treating a New Species: Homo Fragilis]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [A Georgia Woman's Death After Delayed Abortion Care Was Preventable. Who's to Blame?]( CME SPOTLIGHT [Exploring HER2 Targeting: Transforming Treatment for Metastatic and Locally Advanced HER2+ Cancers]( [Screening After False Positive Mammograms; RSV Vaccination and Hospitalization]( [Older Migraine Drugs More Effective Than Newer Ones, Analysis Suggests]( [Brain Training and Memory Decline; Alzheimer's Pioneer Dies; Notorious APOE4]( CME SPOTLIGHT [Updated Treatment Paradigms in HER2+ Breast Cancer]( [Lp(a) Cutoffs by Sex; LBBA Pacing Approvals; Loneliness Not to Blame for CVD?]( [FDA OKs First Flu Vaccine for At-Home Use]( [Chia Seed Medication Interactions; A Star Is Born; Doc Says to #MaskUp]( CME SPOTLIGHT [Precision Targeting in Acute Myeloid Leukemia: Optimizing Disease-Informed, Patient-Centered Care]( [Brain Health Risks: Digital Quality Measures and the Future of Neurological Care]( [Metal Exposure Also Linked to More Coronary Artery Calcium]( [CBT Improved Sex Life For Peri- and Post-Menopausal Women]( CME SPOTLIGHT [Breakthrough Immunotherapies Transforming Early-Stage NSCLC Treatment]( [What to Know About 'Raccoon Roundworm']( ['Failing Wisely' Can Promote a Safer Healthcare System]( [Novel Plant-Based Estrogen Cuts Menopause Symptoms]( CME SPOTLIGHT [Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment]( [Hormone Therapy Reduced Insulin Resistance in Healthy Postmenopausal Women]( [Here Are the Best Private Healthcare Companies to Work For]( [At Catholic Hospitals, Mission of Charity Runs Up Against High Costs for Patients]( CME SPOTLIGHT [Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations]( [What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists?]( [GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death]( ['Is It Safe to Hit a Kid in the Head 200 Times?': What We Heard This Week]( CME SPOTLIGHT [Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies From Leading Experts]( [House Staff Unionization Has Come in Waves]( [Our Patients With Disabilities Face Unique Environmental Risks]( [Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival]( [New Consensus Report: Myopia Should Be Classified as a Disease]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-09-21&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.